Plant protein-based edible film and coatings have emerged as eco-friendly alternatives to synthetic packaging, offering biodegradable, non-toxic solutions. Their biocompatibility and film-forming properties make them suitable for direct application on food products, reducing reliance on non-degradable plastics and lowering environmental pollution. Despite their promising advantages, challenges remain in optimizing mechanical properties, production scalability, and consumer acceptance.
View Article and Find Full Text PDFStarch is one of the most abundant polysaccharides in nature and has a high potential for application in several fields, including effluent treatment as an adsorbent. Starch has a unique structure, with zones of different crystallinity and a glycosidic structure containing hydroxyl groups. This configuration allows a wide range of interactions with pollutants of different degrees of hydrophilicity, which includes from hydrogen bonding to hydrophobic interactions.
View Article and Find Full Text PDFObjective: To evaluate the relationship between infarct pattern, inferred stroke mechanism and risk of recurrence in patients with ischaemic stroke. The question is clinically relevant to optimise secondary stroke prevention investigations and treatment.
Design: We conducted a retrospective analysis of the dabigatran treatment of acute stroke II (DATAS II) trial (ClinicalTrials.
Plant chloroplasts store starch during the day, which acts as a source of carbohydrates and energy at night. Starch granule initiation relies on the elongation of malto-oligosaccharide primers. In Arabidopsis thaliana, PROTEIN TARGETING TO STARCH 2 (PTST2) and STARCH SYNTHASE 4 (SS4) are essential for the selective binding and elongation of malto-oligosaccharide primers, respectively, and very few granules are initiated in their absence.
View Article and Find Full Text PDFBackground: Stroke secondary to intracranial atherosclerotic disease (ICAD) is associated with high recurrence risk despite currently available secondary prevention strategies. In patients with systemic atherosclerosis, a significant reduction of stroke risk with no increase in intracranial or fatal hemorrhage was seen when rivaroxaban 2.5 mg twice daily was added to aspirin.
View Article and Find Full Text PDF